Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
McKesson
Baxter
Farmers Insurance
Dow
Fuji
Johnson and Johnson
Julphar

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065110

« Back to Dashboard

NDA 065110 describes CYCLOSPORINE, which is a drug marketed by Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Sandoz, Luitpold, West-ward Pharms Int, Abbvie, Apotex Inc, and Wockhardt Bio Ag, and is included in eleven NDAs. It is available from ten suppliers. Additional details are available on the CYCLOSPORINE profile page.

The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 065110
Tradename:CYCLOSPORINE
Applicant:Ivax Sub Teva Pharms
Ingredient:cyclosporine
Patents:0
Therapeutic Class:Immunological Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 065110
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYCLOSPORINE cyclosporine CAPSULE;ORAL 065110 ANDA Teva Pharmaceuticals USA Inc 0093-5740 N 0093-5740-65
CYCLOSPORINE cyclosporine CAPSULE;ORAL 065110 ANDA Teva Pharmaceuticals USA Inc 0093-5741 N 0093-5741-65

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Mar 29, 2005TE:AB1RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Mar 29, 2005TE:AB1RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Mar 29, 2005TE:AB1RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Johnson and Johnson
Mallinckrodt
Queensland Health
Medtronic
Cipla
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.